Family history, BRCA mutations and breast cancer in Vietnamese women

Clinical Genetics

Volumn 80, Issue 1, 2011, Pages 89-92

  Ginsburg, Om ^a,b   Dinh, Nv ^c   To, Tv ^c   Quang, Lh ^c   Linh, Nd ^c   Duong, Bth ^c   Royer, R ^a   Llacuachaqui, M ^a   Tulman, A ^a   Vichodez, G ^a   Li, S ^a   Love, Rr ^c   Narod, Sa ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b International Breast Cancer Research Foundation   (United States)

^c National Cancer Hospital   (Viet Nam)

Author keywords

BRCA1; BRCA2; Breast cancer; Vietnamese

Indexed keywords

DNA;

ADULT; AGED; ALLELE; ARTICLE; ASIAN; BREAST CANCER; CANCER INCIDENCE; EXON; FAMILY HISTORY; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; POPULATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VIET NAM;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MUTATION; VIETNAM; YOUNG ADULT;

EID: 79958124129     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2010.01545.x     Document Type: Article

References (31)

1. Deapen D, Liu L, Perkins C, Bernstein L, Ross R. Rapidly rising breast cancer incidence rates among Asian-American women. Int J Cancer 2002: 99: 747-750.
2. Ferlay ACS. Globocan 2002: cancer incidence, mortality and prevalence worldwide IARC CancerBase No 5, version 2.0. Lyon, France: IARC Press, 2004.
3. Anh PTH, Duc NB. The situation with cancer control in Vietnam. Jpn J Clin Oncol 2002: 32 (Suppl): S92-S97.
4. Curado MP, Edwards B, Shin HR et al. eds. Cancer in five continents, Vol IX. IARC Scientific Publications No 160. Lyon, France: IARC Press, 2007.
5. Kwong A, Wong LP, Wong HN et al. A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer. Breast Cancer Res Treat 2009: 117: 683-686.
6. Li W-F, Hu Z, Rao N-Y et al. The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat 2008: 110: 99-109.
7. Chen W, Pan K, Ouyang T et al. BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer. Breast Cancer Res Treat 2009: 117: 55-60.
8. Khoo US, Chan KY, Cheung AN et al. Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population. Hum Mutat 2002: 19: 307-308.
9. Sng JH, Chang J, Feroze F et al. The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives. Br J Cancer 2000: 82: 538-542.
10. Purnomosari D, Pals G, Wahyono A et al. BRCA1 and BRCA2 germline mutation analysis in the Indonesian population. Breast Cancer Res Treat 2007: 106: 297-304.
11. Patmasiriwat P, Bhothisuwan K, Sinilnikova OM et al. Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer. Hum Mutat 2002: 20 (3): 230.
12. Lee ASG, Ho GH, Oh PC et al. Founder mutation in the BRCA1 gene in Malay breast cancer patients from Singapore. Hum Mutat 2003: 22: 178.
13. Ahn SH, Son BH, Yoon K-S et al. BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations. Cancer Lett 2007: 245: 90-95.
14. Sekine M, Nagata H, Tsuji S et al. Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population. Clin Cancer Res 2001: 7: 3144-3150.
15. Ikeda N, Mryoshi Y, Yoneda K et al. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 2001: 91: 83-88.
16. Ye S, Dhillon S, Ke X, Collins AR, Day INM. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001: 29 (17): E88.
17. Leide A, Malik IA, Aziz Z, Pd Pde L, Kwan E, Narod SA. Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. Am J Hum Genet 2002: 71: 595-606.
18. Kuperstein G, Foulkes WD, Ghadirian P, Hakimi J, Narod SA. A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes. Clin Genet 2000: 57: 213-220.
19. Narod SA, Foulkes WD. BRCA1 and BRCA2; 1994 and beyond. Nat Rev Cancer 2004: 4: 665-676.
20. Fackenthal JD, Olopade OI. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 2007: 7: 937-947.
21. Emi M, Matsushima M, Katagiri T et al. Multiplex mutation screening of the BRCA1 gene in 1000 Japanese breast cancers. Jpn J Cancer Res 1998: 89: 12-16.
22. Suter NM, Ray RM, Hu YW et al. BRCA1 and BRCA2 mutations in women from Shanghai China. Cancer Epidemiol Biomarkers Prev 2004: 13: 181-189.
23. Seo JH, Cho DY, Ahn SH et al. BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer. Hum Mutat 2004: 24: 350.
24. De Leon Matsuda ML, Liede A, Kwan E et al. BRCA1 and BRCS2 mutations among breast cancer patients from the Philippines. Int J Cancer 2002: 98: 596-603.
25. Son CG, Hu Z, Wu J et al. The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer. J Cancer Res Clin Oncol 2006: 132: 617-626.
26. Choi DH, Lee MH, Bale AE, Carter D, Haffty BG. Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. J Clin Oncol 2004: 22: 1638-1645.
27. Thirthagiri E, Lee SY, Kang P et al. Evaluation of BRCA1 and BRCA2 mutations and risk models in a typical Asian country (Malaysia) with a low incidence of breast cancer. Breast Cancer Res 2008: 10 (4): 1:R59.
28. Toh GT, Kang P, Lee SSW et al. BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history. PLoS ONE 2008: 3 (4): e2024.
29. Sugano K, Nakamura S, Ando G et al. Cross-sectional analysis of germ-line BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer. Cancer Sci 2008: 99: 1967-1976.
30. Tian C, Kosoy R, Lee A et al. Analysis of East Asia genetic substructure using genome-wide SNP assays. PLoS ONE 2008: 3 (12): e3862.
31. The HUGO Pan-Asian SNP Consortium. Mapping human genetic diversity in Asia. Science 2009: 326: 1541-1545.